Epilepsy Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Epilepsy Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends wrong signals. Seizures could differ from primary generalized seizures to partial seizures depending upon the cause of the epilepsy. Patients suffering from epilepsy may complain about strange emotions and sensations or they may behave strangely. Epilepsy is the fourth most common brain disorder affecting people of all ages. For the treatment of epilepsy, doctors prescribe antiepileptic medicines (AEDs) and the preference for the drug depends on the type of seizures to be treated, age of the patient, part of the brain involved and seriousness of the seizures. On the basis of the available AEDs, epilepsy therapeutics market is segmented into two major categories namely first generation AEDs and second generation AEDs. First generation AEDs consist of following drugs: Carbamazepine (Carbatrol) Valproate (Depakote) Oxycarbazepine ((Trileptal) Phenytoin (Dilantin, Phenytek) Ethosuximide (Zarontin) Phenobarbital (Luminal) Primidone (Mysoline) Topiramate (Topamax) Second generation AEDs consist of medicines with different mechanism of action than the first generation drugs. This segment of epilepsy therapeutics market consists of following drugs: Pregabalin (Lyrica) Lamotrigine (Lamictal) Levetiracetam (Keppra) Zonisamide (Zonegran) Lacosamide (Vimpat) Eslicarbazepine acetate (Aptiom/Zebinix) Perampanel (Fycompa) Ezogabine/retigabine (Trobalt/Potiga) Rufinamide (Banzel/Inovelon) First generation AEDs majorly carbamazepine, valproate, phenytoin and oxycarbazepine dominates the epilepsy therapeutics market. However, second generation AEDs such as levetiracetam, zonisamide and lacosamide are slowly overtaking the epilepsy therapeutics market due to its improved efficacy and...